Qiaochu Li
Thorsten Hoppe- 1Institute for Genetics and Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany
- 2Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany
Mitochondria are central hubs for energy production, metabolism and cellular signal transduction in eukaryotic cells. Maintenance of mitochondrial homeostasis is important for cellular function and survival. In particular, cellular metabolic state is in constant communication with mitochondrial homeostasis. One of the most important metabolic processes that provide energy in the cell is amino acid metabolism. Almost all of the 20 amino acids that serve as the building blocks of proteins are produced or degraded in the mitochondria. The synthesis of the amino acids aspartate and arginine depends on the activity of the respiratory chain, which is essential for cell proliferation. The degradation of branched-chain amino acids mainly occurs in the mitochondrial matrix, contributing to energy metabolism, mitochondrial biogenesis, as well as protein quality control in both mitochondria and cytosol. Dietary supplementation or restriction of amino acids in worms, flies and mice modulates lifespan and health, which has been associated with changes in mitochondrial biogenesis, antioxidant response, as well as the activity of tricarboxylic acid cycle and respiratory chain. Consequently, impaired amino acid metabolism has been associated with both primary mitochondrial diseases and diseases with mitochondrial dysfunction such as cancer. Here, we present recent observations on the crosstalk between amino acid metabolism and mitochondrial homeostasis, summarise the underlying molecular mechanisms to date, and discuss their role in cellular functions and organismal physiology.
Introduction
Mitochondria are the major sites for energy production. The tricarboxylic acid (TCA) cycle and oxidative phosphorylation (OXPHOS) are coupled to metabolize energy sources for cellular function and survival. The close cooperation of these two processes ensures energy homeostasis under changing environmental and internal conditions. In addition to energy production, mitochondria are also hubs of cellular metabolism. A variety of metabolites from the TCA cycle are essential for cellular signaling and macromolecule synthesis (Martínez-Reyes and Chandel, 2020). There is constant communication between mitochondria and cellular metabolic state. Mitochondria are remodelled in response to metabolic changes (Melser et al., 2015; Ni et al., 2015; Mishra and Chan, 2016; Esteban-Martínez et al., 2017). Mechanisms involved include stress-induced transcriptional responses, adaptation of the ubiquitin-proteasome system, regulation of mitochondrial proteolysis activity, or alteration of key molecules for mitochondrial fusion and fission (Lin and Haynes, 2016; Mishra and Chan, 2016; MacVicar et al., 2019; Yue et al., 2022). Metabolic alterations and mitochondrial dysfunction have been linked to a number of diseases, including cancer and neurodegenerative disorders (Pacheu-Grau et al., 2018; Vasan et al., 2020).
Amino acid metabolism is one of the most important sources for energy production in the cell. The metabolic pathways of amino acids are largely associated with mitochondria (Guda et al., 2007). In the following, we discuss the interactions between amino acid metabolism and mitochondrial homeostasis, focusing on two important metabolic processes in mitochondria, TCA cycle and OXPHOS. We then discuss the effects of amino acid supplementation or restriction on longevity, focussing on the remodeling of mitochondrial homeostasis. We also present recent observations on the potential role of amino acid metabolism in diseases associated with mitochondrial dysfunction.
Amino acid metabolism is associated with mitochondria
Amino acids are used for protein synthesis or oxidized as energy sources. In addition, amino acids also serve as precursors of many important metabolites that regulate gene expression, post-translational modifications of proteins, cell fate, etc. (Martínez-Reyes and Chandel, 2020). Amino acid metabolism relies largely on mitochondrial enzymes. For example, the degradation of BCAAs, i.e., valine, leucine, and isoleucine, occurs predominantly in the mitochondria, with the exception of the first transamination step, which is catalysed in the cytoplasm. Dysfunction of mitochondrial enzymes for amino acid metabolism is causally related to a number of mitochondrial diseases or disorders in humans (Guda et al., 2007). In the following sections, we discuss the functional link between mitochondrial homeostasis and amino acid metabolism and its implications in aging and disease.
Maintenance of amino acid levels and mitochondrial homeostasis
Amino acid levels in the cell are constantly monitored and maintained, and the acquisition, storage, and utilization of amino acids are adjusted according to nutrient status of the cell (Efeyan et al., 2015; Schuler et al., 2021). Amino acid deficiency lowers mitochondrial membrane potential and leads to early onset of mitochondrial respiratory quiescence during oogenesis in flies (Sieber et al., 2016; Yue et al., 2022). The lack of amino acids in the cell is sensed by general control non-derepressible 2 (GCN2), which has a high affinity to uncharged tRNAs. Upon binding to an uncharged tRNA, GCN2 undergoes a conformational change and is activated, resulting in inhibitory phosphorylation of eukaryotic translation initiation factor 2α (eIF2α), preventing translation initiation under amino acid deficiency (Figure 1) (Berlanga et al., 1999; Dong et al., 2000).
FIGURE 1. Cellular regulation of amino acid levels and possible physiological/pathological consequences of amino acid deficiency or excess. The lack of amino acids is sensed by GCN2, which is activated upon binding to an uncharged tRNA. Activated GCN2 phosphorylates eIF2α to prevent translation initiation. Amino acid deficiency decreases mitochondrial membrane potential (low membrane potential indicated in grey, otherwise shown in orange). Excess amino acids are imported and sequestered by the lysosome, activate mTORC1, and induce the formation of MDC and MVB. Amino acid deficiency or amino acid overload in the cell can lead to a variety of diseases.
Excess amino acids induce the formation of mitochondrial-derived compartments (MDCs) in yeast and mammalian cells (Schuler et al., 2020; 2021). MDCs remove the outer mitochondrial membrane (OMM) protein Tom70 as well as the inner mitochondrial membrane proteins SLC25A carriers, which are known to be major metabolite exchangers via the inner mitochondrial membrane (Palmieri and Monné, 2016), for metabolic adaptation during amino acid elevation stress. The yeast vacuole, which corresponds to the mammalian lysosome, serves to import and sequester amino acids to avoid amino acid toxicity (Hughes and Gottschling, 2012; Hughes et al., 2020). At the same time, the endosomal sorting complexes required for transport-dependent multivesicular body (MVB) pathway ensures that nutrient transporters are removed at the plasma membrane along with MDCs and vacuoles to protect cells from amino acid overload (Figure 1) (Schuler et al., 2021). Interesting, leucine appears to be the strongest activator for both MDC formation and mTORC1 activation (Hara et al., 1998; Schuler et al., 2021). In addition, GCN2 knockout mice fed a leucine deficiency diet show more severe effects on new born mouse viability compared with tryptophan or glycine deficiency diets (Zhang et al., 2002). This suggests an important role for leucine in mitochondrial adaptation to nutrient changes. Amino acid deficiency or amino acid overload can lead to a variety of diseases (Koning, 2017; Aliu et al., 2018) (Figure 1).
Sensing of amino acid by mTOR has been shown to contribute to various aspects of aging and disease. For example, mice treated with a special blend of essential amino acids (EAAs) enriched in BCAAs show increased mTOR activity and mitochondrial biogenesis in skeletal muscle and hippocampus, as well as better physical and cognitive performance in aging compared to control-treated animals (Brunetti et al., 2020). Amino acid activation of mTOR has also been linked to the reduction of toxic effects of some chemotherapeutic agents such as doxorubicin by preventing the doxorubicin-dependent mitochondrial damage and oxidative stress (Tedesco et al., 2020). Because activation of mTOR inhibits autophagy, which is essential for the removal of unneeded or damaged proteins and organelles, there is evidence that amino acids may contribute to cognitive decline and synaptic dysfunction at least in part via activation of mTOR (Meijer et al., 2015; Wang et al., 2022). In some other cases, e.g., in rats in the maple syrup urine disease model, BCAA administration has been reported to increase autophagy in brain tissue (Fermo et al., 2023). Regulation of mTOR by amino acids also plays an essential role in neuronal development, which was studied recently (Takei and Nawa, 2014).
TCA cycle and amino acid metabolism
The TCA cycle is a series of metabolic reactions that occurs in the mitochondrial matrix. The oxidation of fatty acids, glucose, and amino acids produces acetyl-CoA, and the TCA cycle uses acetyl-CoA to produce NADH and FADH2. NADH and FADH2 are then used for ATP production in the respiratory chain. The TCA cycle is not only involved in catabolism, but is also critical for the biosynthesis of a number of molecules including amino acids, lipids, and nucleotide bases (Owen et al., 2002). The components of the TCA cycle serve as precursors for the synthesis of non-essential amino acids, which account for more than 50% of protein carbon (Roberts et al., 1953). For example, the synthesis of glutamic acid and aspartate requires the TCA cycle metabolites alpha-ketoglutarate and oxaloacetate, respectively (Figure 2) (Owen et al., 2002). Detailed regulation and function of TCA cycle has been recently reviewed (Arnold and Finley, 2023).
FIGURE 2. Changes of amino acid metabolism upon TCA cycle and respiratory chain inhibition. The TCA cycle is involved in both catabolism and anabolism of amino acids. The TCA cycle and the respiratory chain are closely linked both physically and functionally. Inhibition of TCA cycle and respiratory chain affect amino acid metabolism.
Although TCA cycle is at the nexus of both catabolic and anabolic metabolism involving different key fuel molecules and metabolites, it was recently reported that alteration of amino acid metabolism is the main consequence of TCA cycle disruption (Ryan et al., 2021). Acute inhibition of the TCA cycle (TCAi) in mouse kidney epithelial cells results in increased glutathione synthesis and impaired proline and aspartate synthesis (Figure 2). Transcriptome analyses of cells with acute TCAi showed robust activation of the response to amino acid deprivation. In addition, there appears to be activation of the integrated stress response in TCAi cells to counteract redox and amino acid stress. Chronic TCAi, achieved by genetic ablation of the two TCA cycle enzymes fumarate hydratase or succinate dehydrogenase, results in increased intracellular cystine, serine, glycine, and asparagine levels (Figure 2). This suggests that chronic disruption of the TCA cycle, as opposed to acute inhibition, may be an adaptive response to metabolic changes. Impaired mitochondrial thiol redox homeostasis causes a similar phenomenon to TCA cycle inhibition, suggesting an important interaction between the TCA cycle, redox biology, and amino acid homeostasis (Ryan et al., 2021). Interestingly, inhibition of different enzymes in the TCA cycle results in different regulation of amino acid metabolism, although common features are evident (Ryan et al., 2021). This suggests that amino acid metabolism is sensitive to specific changes of the TCA cycle and that regulation of amino acid metabolism is adjusted according to this specific change. Since this study is performed in mouse kidney epithelial cells, it would be interesting to see whether these findings apply to different cell types or different tissues, or whether this is conversed across species.
Respiratory chain activity and amino acid synthesis
Mitochondrial OXPHOS is central to cellular energy production. The OXPHOS system includes five enzyme complexes and two mobile electron carriers (ubiquinone and cytochrome c) that drive the production of ATP (Vercellino and Sazanov, 2022). Similar to the TCA cycle, OXPHOS is not only involved in catabolism for energy production, but also plays an essential role in anabolism, where the synthesis of some amino acids depends on OXPHOS activity as a key to cell proliferation. Inhibition of respiratory chain activity results in auxotrophy for electron acceptors, inhibiting aspartate synthesis and limiting cell proliferation. Addition of pyruvate or alpha-ketobutyrate as exogenous electron acceptors rescues cell proliferation of respiratory-deficient cells. Addition of aspartate restores proliferation in cells lacking an electron acceptor, suggesting that respiratory chain activity is critical for cells to generate aspartate (Birsoy et al., 2015; Cardaci et al., 2015; Sullivan et al., 2015). In addition to aspartate, it has been observed in mouse renal epithelial cells that inhibition of complex III with antimycin A also significantly decreases asparagine and proline content while promoting glutathione synthesis (Ryan et al., 2021).
Mitochondrial respiration in fission yeasts is also required for the provision of amino acids during fermentative propagation (Malecki et al., 2020). Interestingly, supplementation of arginine alone is sufficient for rapid cell growth when the respiratory chain is inhibited, rather than requiring all amino acids. Moreover, not only arginine but also amino acids from the TCA cycle, i.e., glutamine, glutamic acid, and lysine, are required for rapid cell growth when the respiratory chain is blocked (Figure 2) (Malecki et al., 2020). In addition, blocking respiration leads to transient inhibition of TOR, which depends on the AMPK signaling pathway (Malecki et al., 2020). The fact that glutamine, lysine, and glutamic acid are derivatives of alpha-ketoglutarate produced by the TCA cycle suggests inhibition of the TCA cycle when the respiratory chain is inactivated. This is to be expected because the TCA cycle and OXPHOS are both physically and functionally coupled. The utilization of NADH and FADH2 in complexes I and II is required for the TCA cycle to continue to function. There is further evidence of close cooperation between the TCA cycle respiratory chain activity in response to stress. For example, inhibition of respiration leads to a transcriptional switch in the expression of TCA cycle genes in fission yeast to replenish TCA cycle metabolites that support anabolic pathways (Liu and Butow, 1999). Overall, respiratory chain activity plays a key role in supporting amino acid homeostasis and cell proliferation, although the specific mechanisms vary among different organisms studied to date. Coordination between the TCA cycle, OXPHOS, and amino acid metabolism may be an important mechanism for cells to cope with stress conditions.
Proteasome-mediated recycling of amino acids and mitochondrial homeostasis
Inhibition of the proteasome results in decreased levels of intracellular amino acids and causes mortality. Interestingly, the deleterious effect of proteasome inhibition can be reversed by amino acid supplementation (Suraweera et al., 2012). This finding highlights the important role of amino acid recycling by the 26S proteasome in cellular survival, although it remains unclear how free amino acid content affects cellular physiology. Despite the role of amino acids in protein synthesis, another important aspect is mitochondrial homeostasis due to the close interaction between amino acid metabolism and mitochondria. Amino acid deficiency can directly disrupt the TCA cycle and the respiratory chain, leading to cellular energy failure. In addition, lysosomal recycling of lysine and arginine has been shown to be important for ER quality control (Higuchi-Sanabria et al., 2020). It would be interesting to see whether this is specific to lysosomal function or also applies to proteasome-dependent amino acid recycling. Furthermore, disruption of the mitochondrial respiratory chain or BCAA catabolism impairs proteasomal degradation in the cytoplasm (Segref et al., 2014; Ravanelli et al., 2022). This suggests that mitochondrial activity influences ubiquitin-mediated proteasomal protein turnover, and hence amino acid availability in the cell, which may represent a feedback mechanism for both amino acid metabolism and mitochondrial homeostasis. A recent finding shows that cells lacking ATAD1, an AAA + ATPase that removes substrate proteins directly from the OMM for degradation, are hypersensitive to proteasomal inhibition (Winter et al., 2022). This again points to the importance of the interaction between proteasome function and mitochondrial homeostasis.
Since mitochondria synthesize and degrade proteins independently, the question arises whether the availability of free amino acids affects protein turnover in mitochondria and how it influences the balance between mitochondrial and cytosolic proteins. Imbalance between mitochondrial and cytosolic proteins impairs mitochondrial function (Wang et al., 2021).
Amino acid metabolism, mitochondrial dynamics and mitochondrial quality control
An interesting aspect yet has been little explored is how mitochondrial dynamics and quality control mechanisms may communicate with amino acid metabolism. Mitochondrial fission and fusion are important mechanisms for metabolic adaptation. OXPHOS activity and oxidative stress are associated with the regulation of mitochondrial fusion via modulation of Opa1, an important molecule for inner membrane fusion, while starvation and OXPHOS activity regulate mitochondrial fission via modulation of Drp1, a GTPase recruited to OMM to mediate mitochondrial fission (Mishra and Chan, 2016). However, much less is known about how amino acid metabolism may regulate mitochondrial dynamics. Moreover, mitochondrial quality control ensures proper mitochondrial function by removing damaged or unneeded mitochondrial proteins or, at some point, the entire organism (Song et al., 2021). The mitochondrial proteome is drastically remodelled under metabolic stress conditions. A previous study has shown that lipid metabolism regulates the activity of YME1L proteolysis, which remodels the mitochondrial proteome (MacVicar et al., 2019), but whether and how amino acid metabolism is linked to mitochondrial quality control remains to be investigated. Other mechanisms of mitochondrial quality control include mitochondria-associated degradation, mitophagy and mitochondria-derived vesicles (Song et al., 2021). It would be interesting to study how amino acid stress affects the machinery of mitochondrial quality control and its role in adaptation to stress conditions.
Amino acid metabolism and lifespan regulation
Dietary control or supplementation of amino acids has been shown to affect lifespan in various organisms including worms, flies, and mice. In Caenorhabditis elegans, supplementation of individual amino acids, with the exception of phenylalanine and aspartate, extended lifespan (Edwards et al., 2015). Administration of amino acids to complex I or complex II mutant worms revealed that complex I activity is required for complete serine- and histidine-mediated life extension, while complex II activity is required for proline-mediated life extension (Edwards et al., 2015). Supplementation of TCA cycle intermediates also affects lifespan. Treatment with isocitrate, alpha-ketoglutarate, or succinate at optimal concentrations increased lifespan, whereas supplementation of D-malate at a concentration of 1–10 mM decreased lifespan (Edwards et al., 2015). These results suggest that lifespan extension is closely linked to TCA cycle and respiratory chain activity. In Drosophila, restriction of the essential amino acids methionine, threonine, histidine, lysine, or BCAAs extends lifespan (Lee et al., 2014; Juricic et al., 2019; Richardson et al., 2021). In rodents, dietary restriction of BCAAs increases mouse health and longevity (Richardson et al., 2021). When dietary restriction mice were fed EAAs but not non-essential amino acids, the effect of dietary restriction-dependent longevity prolongation was reduced (Yoshida et al., 2018). These observations indicate that EAAs have a robust effect on lifespan in flies and mice.
Some studies suggest that high concentrations of BCAAs selectively disrupt mitochondrial pyruvate utilization in a mouse model of ischemic heart injury (Li et al., 2017), while others showed that a BCAA-enriched mixture increased the average lifespan of mice, increased mitochondrial biogenesis and sirtuin one expression in primary cardiac and skeletal myocytes and in cardiac and skeletal muscle of middle-aged mice, and upregulated reactive oxygen species defense system genes (D’Antona et al., 2010). The discrepancy between the effects of BCAA on lifespan needs further investigation. Nonetheless, these data demonstrate an important role of BCAAs in aging through the regulation of mammalian mitochondrial homeostasis. Overall, amino acid metabolism plays an important role in regulating longevity, with mitochondrial homeostasis being at least one of the important mechanisms mediating the effect of amino acids on life expectancy.
Amino acid metabolism and mitochondrial dysfunction related diseases
Human mitochondrial diseases (MDs) are often associated with metabolic abnormalities. A detailed discussion of MDs has been reviewed recently (Rahman and Rahman, 2018). Here we specifically discuss how impaired amino acid metabolism may be involved in mitochondrial dysfunction and disease. Altered concentration of certain amino acids is observed in a number of mitochondrial diseases and cancer. In addition to alanine, a standard blood biomarker in MDs (Shaham et al., 2010), patients with primary mitochondrial respiratory chain disease also have significantly elevated levels of BCAAs (Clarke et al., 2013). A recent metabolomic analysis of MDs revealed that a multi-biomarker of four metabolites in blood (sorbitol, alanine, myoinositol, cystathionine) is specific for primary MDs (Buzkova et al., 2018). In addition to the observed changes of amino acid concentration, mutations of mitochondrial enzymes for amino acid metabolism lead to severe metabolic diseases (Guda et al., 2007). For example, mutations in the IVD gene encoding the enzyme for leucine degradation cause isovaleric acidemia, in which the intermediate isovaleric acid accumulates and damages the brain and nervous system (Vockley and Ensenauer, 2006). The deleterious effect of accumulated isovaleric acid is closely linked to proteasomal activity (Segref et al., 2014; Ravanelli et al., 2022).
Glutamine metabolism plays an important role in both MDs and cancer due to its versatile role in cell metabolism (Yoo et al., 2020). Cells with an mtDNA mutation have altered levels of glutamine and glutamine metabolites. These cells have a defect in OXPHOS and rely on oxidative glutamine-glutamate-alpha-ketoglutarate metabolism for survival (Figure 2). Alpha-ketoglutarate supplementation improves the survival of mtDNA-mutated cells (Chen et al., 2018). Moreover, glutamate metabolism is altered in a mouse model of mitochondrial myopathy, and alpha-ketoglutarate supplementation rescues amino acid imbalance in muscle. These results suggest that alpha-ketoglutarate supplementation may be a therapeutic strategy for mitochondrial myopathies (Chen et al., 2018). In addition, the important role of glutamine in cell proliferation makes it a target for cancer treatment. Agents targeting glutamine metabolism, such as glutaminase or conversion of glutamate to alpha-ketoglutarate, have been developed (Zhang et al., 2017). Besides glutamine, other amino acids have also been linked to cancer. For example, LAT1 (SLC7A5), the major BCAA transporter, is highly expressed in many cancers, including lung cancer, prostate, and breast cancers (Singh and Ecker, 2018; Häfliger and Charles, 2019). The serine transporter ASCT1 (SLC1A4) is upregulated in both breast cancer and lung cancer (Pollari et al., 2011; Maddocks et al., 2016). In addition, amino acids are important for fetal development. Decreased placental transfer of essential amino acids is a common feature in human and animal models of intrauterine growth restriction (Ross, et al., 1996; Anderson et al., 1997; Jansson et al., 1998; Paolini et al., 2001). The role of dietary amino acids in reproductive disorders was reviewed recently (Hussain et al., 2020). Alterations in amino acid metabolism have been associated with mitochondrial dysfunction as well as underlying diseases such as cancer and fetal growth restriction syndrome. A better understanding of the communication between amino acid metabolism and mitochondrial homeostasis may be important for new therapies for diseases with mitochondrial dysfunction.
Conclusions and perspectives
Changes in mitochondrial dynamics and functionality are often accompanied by metabolic adaptions, and cellular metabolic changes in turn lead to mitochondrial remodeling. Metabolism of most amino acids depends on the proper function of mitochondrial enzymes. Metabolic intermediates of amino acids are fed into the TCA cycle, and metabolites from the TCA cycle serve as precursors for amino acid synthesis. Dietary control or supplementation of amino acids has profound effects on the regulation of lifespan in various organisms, including worms, flies, and rodents. These age-related effects of amino acids occur directly or indirectly through the regulation of mitochondrial function. Certain amino acids such as alanine and BCAAs have been shown to be significantly elevated in primary MDs. Rewiring of the metabolic pathways of glutamine and other amino acids is thought to be an important bioenergetic adaptation in OXPHOS-defective cells or cancer cells. Recent studies have highlighted the role of the TCA cycle and respiratory chain activity in coordinating amino acid metabolism and mitochondrial homeostasis. Disruption of the TCA cycle or respiratory chain activity often has a reciprocal effect. Therefore, it is unclear whether many of the observed phenotypes are a direct consequence of inhibition of the TCA cycle or the respiratory chain. This should be considered in future studies. Dietary control or supplementation of amino acids regulates longevity, although the effects on longevity are contradictory in some cases. Dietary supplementation of most amino acids increases lifespan in worms, whereas restriction of essential amino acids extends lifespan in most studies in flies and mice. This may be due to the different preferred pathways of nutrient utilization in different organisms or to the dose and duration of amino acid supplementation. The sensitivity of different tissues to amino acid supplementation may also lead to different effects on lifespan. More detailed molecular mechanisms need to be characterized, particularly mitochondrial restructuring after amino acid treatment. In addition, the short- and long-term effects of amino acid supplementation on mitochondrial physiology, such as mitochondrial morphology and oxygen consumption, will be analysed. Furthermore, mitochondrial mass and metabolic activity vary in different tissues and cell types. Sensitivity to different mitochondrial gene mutations varies in different tissues, sometimes resulting in tissue-specific phenotypes and diseases (Pacheu-Grau et al., 2018). The interaction between amino acid metabolism and mitochondria may also have tissue-specific features that should be further investigated. Finally, amino acid metabolism offers therapeutic potential for MDs, cancer, and other diseases associated with mitochondrial dysfunction.
Author contributions
QL and TH conceived and wrote the manuscript. QL designed all figures.
Funding
This work was funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany’s Excellence Strategy–EXC 2030–390661388 and–SFB 1218—Project Number 269925409 to TH Diese Arbeit wurde gefördert von der Deutschen Forschungsgemeinschaft (DFG) im Rahmen der deutschen Exzellenzstrategie—EXC 2030–390661388 und–SFB 1218—Projekt Nummer 269925409 an TH. QL is supported by a postdoctoral fellowship from the Alexander von Humboldt Foundation.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
Aliu, E., Kanungo, S., and Arnold, G. L. (2018). Amino acid disorders. Ann. Transl. Med. 6, 471. doi:10.21037/atm.2018.12.12
Anderson, A. H., Fennessey, P. V., Meschia, G., Wilkening, R. B., and Battaglia, F. C. (1997). Placental transport of threonine and its utilization in the normal and growth-restricted fetus. Am. J. Physiol-endoc M. 272, E892–E900. doi:10.1152/ajpendo.1997.272.5.e892
Arnold, P. K., and Finley, L. W. S. (2023). Regulation and function of the mammalian tricarboxylic acid cycle. J. Biol. Chem. 299, 102838. doi:10.1016/j.jbc.2022.102838
Berlanga, J. J., Santoyo, J., and Haro, C. D. (1999). Characterization of a mammalian homolog of the GCN2 eukaryotic initiation factor 2alpha kinase. Eur. J. Biochem. 265, 754–762. doi:10.1046/j.1432-1327.1999.00780.x
Birsoy, K., Wang, T., Chen, W. W., Freinkman, E., Abu-Remaileh, M., and Sabatini, D. M. (2015). An essential role of the mitochondrial electron transport chain in cell proliferation is to enable aspartate synthesis. Cell 162, 540–551. doi:10.1016/j.cell.2015.07.016
Brunetti, D., Bottani, E., Segala, A., Marchet, S., Rossi, F., Orlando, F., et al. (2020). Targeting multiple mitochondrial processes by a metabolic modulator prevents sarcopenia and cognitive decline in SAMP8 mice. Front. Pharmacol. 11, 1171. doi:10.3389/fphar.2020.01171
Buzkova, J., Nikkanen, J., Ahola, S., Hakonen, A. H., Sevastianova, K., Hovinen, T., et al. (2018). Metabolomes of mitochondrial diseases and inclusion body myositis patients: Treatment targets and biomarkers. Embo Mol. Med. 10, e9091. doi:10.15252/emmm.201809091
Cardaci, S., Zheng, L., MacKay, G., Broek, N. J. F., MacKenzie, E. D., Nixon, C., et al. (2015). Pyruvate carboxylation enables growth of SDH-deficient cells by supporting aspartate biosynthesis. Nat. Cell Biol. 17, 1317–1326. doi:10.1038/ncb3233
Chen, Q., Kirk, K., Shurubor, Y. I., Zhao, D., Arreguin, A. J., Shahi, I., et al. (2018). Rewiring of glutamine metabolism is a bioenergetic adaptation of human cells with mitochondrial DNA mutations. Cell Metab. 27, 1007–1025.e5. doi:10.1016/j.cmet.2018.03.002
Clarke, C., Xiao, R., Place, E., Zhang, Z., Sondheimer, N., Bennett, M., et al. (2013). Mitochondrial respiratory chain disease discrimination by retrospective cohort analysis of blood metabolites. Mol. Genet. Metab. 110, 145–152. doi:10.1016/j.ymgme.2013.07.011
D’Antona, G., Ragni, M., Cardile, A., Tedesco, L., Dossena, M., Bruttini, F., et al. (2010). Branched-chain amino acid supplementation promotes survival and supports cardiac and skeletal muscle mitochondrial biogenesis in middle-aged mice. Cell Metab. 12, 362–372. doi:10.1016/j.cmet.2010.08.016
Dong, J., Qiu, H., Garcia-Barrio, M., Anderson, J., and Hinnebusch, A. G. (2000). Uncharged tRNA activates GCN2 by displacing the protein kinase moiety from a bipartite tRNA-binding domain. Mol. Cell 6, 269–279. doi:10.1016/s1097-2765(00)00028-9
Edwards, C., Canfield, J., Copes, N., Brito, A., Rehan, M., Lipps, D., et al. (2015). Mechanisms of amino acid-mediated lifespan extension in Caenorhabditis elegans. Bmc Genet. 16, 8. doi:10.1186/s12863-015-0167-2
Efeyan, A., Comb, W. C., and Sabatini, D. M. (2015). Nutrient-sensing mechanisms and pathways. Nature 517, 302–310. doi:10.1038/nature14190
Esteban-Martínez, L., Sierra-Filardi, E., and Boya, P. (2017). Mitophagy, metabolism, and cell fate. Mol. Cell Oncol. 4, e1353854. doi:10.1080/23723556.2017.1353854
Fermo, K. T., Lemos, I. da S., Farias, H. R., Rosso, M. P., Effting, P. S., Leipnitz, G., et al. (2023). Branched-chain amino acids (BCAA) administration increases autophagy and the autophagic pathway in brain tissue of rats submitted to a Maple Syrup Urine Disease (MSUD) protocol. Metab. Brain Dis. 38, 287–293. doi:10.1007/s11011-022-01109-y
Guda, P., Guda, C., and Subramaniam, S. (2007). Reconstruction of pathways associated with amino acid metabolism in human mitochondria. Genom Proteom Bioinform 5, 166–176. doi:10.1016/s1672-0229(08)60004-2
Häfliger, P., and Charles, R.-P. (2019). The L-type amino acid transporter LAT1—an emerging target in cancer. Int. J. Mol. Sci. 20, 2428. doi:10.3390/ijms20102428
Hara, K., Yonezawa, K., Weng, Q.-P., Kozlowski, M. T., Belham, C., and Avruch, J. (1998). Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism. J. Biol. Chem. 273, 14484–14494. doi:10.1074/jbc.273.23.14484
Higuchi-Sanabria, R., Shen, K., Kelet, N., Frankino, P. A., Durieux, J., Bar-Ziv, R., et al. (2020). Lysosomal recycling of amino acids affects ER quality control. Sci. Adv. 6, eaaz9805. eaaz9805. doi:10.1126/sciadv.aaz9805
Hughes, A. L., and Gottschling, D. E. (2012). An early age increase in vacuolar pH limits mitochondrial function and lifespan in yeast. Nature 492, 261–265. doi:10.1038/nature11654
Hughes, C. E., Coody, T. K., Jeong, M.-Y., Berg, J. A., Winge, D. R., and Hughes, A. L. (2020). Cysteine toxicity drives age-related mitochondrial decline by altering iron homeostasis. Cell 180, 296–310.e18. doi:10.1016/j.cell.2019.12.035
Hussain, T., Tan, B., Murtaza, G., Metwally, E., Yang, H., Kalhoro, M. S., et al. (2020). Role of dietary amino acids and nutrient sensing system in pregnancy associated disorders. Front. Pharmacol. 11, 586979. doi:10.3389/fphar.2020.586979
Jansson, T., Scholtbach, V., and Powell, T. L. (1998). Placental transport of leucine and lysine is reduced in intrauterine growth restriction. Pediatr. Res. 44, 532–537. doi:10.1203/00006450-199810000-00011
Juricic, P., Grönke, S., and Partridge, L. (2019). Branched-chain amino acids have equivalent effects to other essential amino acids on lifespan and ageing-related traits in Drosophila. Journals Gerontol. Ser. 75, glz080. doi:10.1093/gerona/glz080
Koning, T. J. de (2017). Amino acid synthesis deficiencies. J. Inherit. Metab. Dis. 40, 609–620. doi:10.1007/s10545-017-0063-1
Lee, B. C., Kaya, A., Ma, S., Kim, G., Gerashchenko, M. V., Yim, S. H., et al. (2014). Methionine restriction extends lifespan of Drosophila melanogaster under conditions of low amino-acid status. Nat. Commun. 5, 3592. doi:10.1038/ncomms4592
Li, T., Zhang, Z., Kolwicz, S. C., Abell, L., Roe, N. D., Kim, M., et al. (2017). Defective branched-chain amino acid catabolism disrupts glucose metabolism and sensitizes the heart to ischemia-reperfusion injury. Cell Metab. 25, 374–385. doi:10.1016/j.cmet.2016.11.005
Lin, Y.-F., and Haynes, C. M. (2016). Metabolism and the UPRmt. Mol. Cell 61, 677–682. doi:10.1016/j.molcel.2016.02.004
Liu, Z., and Butow, R. A. (1999). A transcriptional switch in the expression of yeast tricarboxylic acid cycle genes in response to a reduction or loss of respiratory function. Mol. Cell Biol. 19, 6720–6728. doi:10.1128/mcb.19.10.6720
MacVicar, T., Ohba, Y., Nolte, H., Mayer, F. C., Tatsuta, T., Sprenger, H.-G., et al. (2019). Lipid signalling drives proteolytic rewiring of mitochondria by YME1L. Nature 575, 361–365. doi:10.1038/s41586-019-1738-6
Maddocks, O. D. K., Labuschagne, C. F., Adams, P. D., and Vousden, K. H. (2016). Serine metabolism supports the methionine cycle and DNA/RNA methylation through de novo ATP synthesis in cancer cells. Mol. Cell 61, 210–221. doi:10.1016/j.molcel.2015.12.014
Malecki, M., Kamrad, S., Ralser, M., and Bähler, J. (2020). Mitochondrial respiration is required to provide amino acids during fermentative proliferation of fission yeast. Embo Rep. 21, e50845. doi:10.15252/embr.202050845
Martínez-Reyes, I., and Chandel, N. S. (2020). Mitochondrial TCA cycle metabolites control physiology and disease. Nat. Commun. 11, 102. doi:10.1038/s41467-019-13668-3
Meijer, A. J., Lorin, S., Blommaart, E. F., and Codogno, P. (2015). Regulation of autophagy by amino acids and MTOR-dependent signal transduction. Amino Acids 47, 2037–2063. doi:10.1007/s00726-014-1765-4
Melser, S., Lavie, J., and Bénard, G. (2015). Mitochondrial degradation and energy metabolism. Biochimica Biophysica Acta Bba - Mol Cell Res 1853, 2812–2821. doi:10.1016/j.bbamcr.2015.05.010
Mishra, P., and Chan, D. C. (2016). Metabolic regulation of mitochondrial dynamics. J. Cell Biol. 212, 379–387. doi:10.1083/jcb.201511036
Ni, H.-M., Williams, J. A., and Ding, W.-X. (2015). Mitochondrial dynamics and mitochondrial quality control. Redox Biol. 4, 6–13. doi:10.1016/j.redox.2014.11.006
Owen, O. E., Kalhan, S. C., and Hanson, R. W. (2002). The key role of anaplerosis and cataplerosis for citric acid cycle function. J. Biol. Chem. 277, 30409–30412. doi:10.1074/jbc.r200006200
Pacheu-Grau, D., Rucktäschel, R., and Deckers, M. (2018). Mitochondrial dysfunction and its role in tissue-specific cellular stress. Cell Stress 2, 184–199. doi:10.15698/cst2018.07.147
Palmieri, F., and Monné, M. (2016). Discoveries, metabolic roles and diseases of mitochondrial carriers: A review. Biochimica Biophysica Acta Bba - Mol Cell Res 1863, 2362–2378. doi:10.1016/j.bbamcr.2016.03.007
Paolini, C. L., Marconi, A. M., Ronzoni, S., Noio, M. D., Fennessey, P. V., Pardi, G., et al. (2001). Placental transport of leucine, phenylalanine, Glycine, and proline in intrauterine growth-restricted pregnancies. J. Clin. Endocrinol. Metab. 86, 5427–5432. doi:10.1210/jcem.86.11.8036
Pollari, S., Käkönen, S.-M., Edgren, H., Wolf, M., Kohonen, P., Sara, H., et al. (2011). Enhanced serine production by bone metastatic breast cancer cells stimulates osteoclastogenesis. Breast Cancer Res. Tr. 125, 421–430. doi:10.1007/s10549-010-0848-5
Rahman, J., and Rahman, S. (2018). Mitochondrial medicine in the omics era. Lancet 391, 2560–2574. doi:10.1016/s0140-6736(18)30727-x
Ravanelli, S., Li, Q., Annibal, A., Trifunovic, A., Antebi, A., and Hoppe, T. (2022). Reprograming of proteasomal degradation by branched chain amino acid metabolism. Aging Cell 21, e13725. doi:10.1111/acel.13725
Richardson, N. E., Konon, E. N., Schuster, H. S., Mitchell, A. T., Boyle, C., Rodgers, A. C., et al. (2021). Lifelong restriction of dietary branched-chain amino acids has sex-specific benefits for frailty and lifespan in mice. Nat. Aging 1, 73–86. doi:10.1038/s43587-020-00006-2
Roberts, R. B., Cowie, D. B., Britten, R., Bolton, E., and Abelson, P. H. (1953). The role of the tricarboxylic acid cycle in amino acid synthesis in Escherichia coli. Proc. Natl. Acad. Sci. 39, 1013–1019. doi:10.1073/pnas.39.10.1013
Ross, J. C., Fennessey, P. V., Wilkening, R. B., Battaglia, F. C., and Meschia, G. (1996). Placental transport and fetal utilization of leucine in a model of fetal growth retardation. Am. J. Physiol-endoc M. 270, E491–E503. doi:10.1152/ajpendo.1996.270.3.e491
Ryan, D. G., Yang, M., Prag, H. A., Blanco, G. R., Nikitopoulou, E., Segarra-Mondejar, M., et al. (2021). Disruption of the TCA cycle reveals an ATF4-dependent integration of redox and amino acid metabolism. Elife 10, e72593. doi:10.7554/elife.72593
Schuler, M.-H., English, A. M., VanderMeer, L., Shaw, J. M., and Hughes, A. L. (2020). Amino acids promote mitochondrial-derived compartment formation in mammalian cells. Biorxiv 23, 424218. doi:10.1101/2020.12.23.424218
Schuler, M.-H., English, A. M., Xiao, T., Campbell, T. J., Shaw, J. M., and Hughes, A. L. (2021). Mitochondrial-derived compartments facilitate cellular adaptation to amino acid stress. Mol. Cell 81, 3786–3802.e13. doi:10.1016/j.molcel.2021.08.021
Segref, A., Kevei, É., Pokrzywa, W., Schmeisser, K., Mansfeld, J., Livnat-Levanon, N., et al. (2014). Pathogenesis of human mitochondrial diseases is modulated by reduced activity of the ubiquitin/proteasome system. Cell Metab. 19, 642–652. doi:10.1016/j.cmet.2014.01.016
Shaham, O., Slate, N. G., Goldberger, O., Xu, Q., Ramanathan, A., Souza, A. L., et al. (2010). A plasma signature of human mitochondrial disease revealed through metabolic profiling of spent media from cultured muscle cells. Proc. Natl. Acad. Sci. 107, 1571–1575. doi:10.1073/pnas.0906039107
Sieber, M. H., Thomsen, M. B., and Spradling, A. C. (2016). Electron transport chain remodeling by GSK3 during oogenesis connects nutrient state to reproduction. Cell 164, 420–432. doi:10.1016/j.cell.2015.12.020
Singh, N., and Ecker, G. F. (2018). Insights into the structure, function, and ligand discovery of the large neutral amino acid transporter 1, LAT1. Int. J. Mol. Sci. 19, 1278. doi:10.3390/ijms19051278
Song, J., Herrmann, J. M., and Becker, T. (2021). Quality control of the mitochondrial proteome. Nat. Rev. Mol. Cell Bio 22, 54–70. doi:10.1038/s41580-020-00300-2
Sullivan, L. B., Gui, D. Y., Hosios, A. M., Bush, L. N., Freinkman, E., and Vander Heiden, M. G. (2015). Supporting aspartate biosynthesis is an essential function of respiration in proliferating cells. Cell 162, 552–563. doi:10.1016/j.cell.2015.07.017
Suraweera, A., Münch, C., Hanssum, A., and Bertolotti, A. (2012). Failure of amino acid homeostasis causes cell death following proteasome inhibition. Mol. Cell 48, 242–253. doi:10.1016/j.molcel.2012.08.003
Takei, N., and Nawa, H. (2014). mTOR signaling and its roles in normal and abnormal brain development. Front. Mol. Neurosci. 7, 28. doi:10.3389/fnmol.2014.00028
Tedesco, L., Rossi, F., Ragni, M., Ruocco, C., Brunetti, D., Carruba, M. O., et al. (2020). A special amino-acid formula tailored to boosting cell respiration prevents mitochondrial dysfunction and oxidative stress caused by doxorubicin in mouse cardiomyocytes. Nutrients 12, 282. doi:10.3390/nu12020282
Vasan, K., Werner, M., and Chandel, N. S. (2020). Mitochondrial metabolism as a target for cancer therapy. Cell Metab. 32, 341–352. doi:10.1016/j.cmet.2020.06.019
Vercellino, I., and Sazanov, L. A. (2022). The assembly, regulation and function of the mitochondrial respiratory chain. Nat. Rev. Mol. Cell Bio 23, 141–161. doi:10.1038/s41580-021-00415-0
Vockley, J., and Ensenauer, R. (2006). Isovaleric acidemia: New aspects of genetic and phenotypic heterogeneity. Am. J. Med. Genet. Part C Semin. Med. Genet. 142C, 95–103. doi:10.1002/ajmg.c.30089
Wang, D., Ye, J., Shi, R., Zhao, B., Liu, Z., Lin, W., et al. (2022). Dietary protein and amino acid restriction: Roles in metabolic health and aging-related diseases. Free Radic. Bio Med. 178, 226–242. doi:10.1016/j.freeradbiomed.2021.12.009
Wang, F., Zhang, D., Zhang, D., Li, P., and Gao, Y. (2021). Mitochondrial protein translation: Emerging roles and clinical significance in disease. Front. Cell Dev. Biol. 9, 675465. doi:10.3389/fcell.2021.675465
Winter, J. M., Fresenius, H. L., Cunningham, C. N., Wei, P., Keys, H. R., Berg, J. A., et al. (2022). Collateral deletion of the mitochondrial AAA+ ATPase ATAD1 sensitizes cancer cells to proteasome dysfunction. Elife 11, e82860. doi:10.7554/elife.82860
Yoo, H. C., Yu, Y. C., Sung, Y., and Han, J. M. (2020). Glutamine reliance in cell metabolism. Exp. Mol. Med. 52, 1496–1516. doi:10.1038/s12276-020-00504-8
Yoshida, S., Yamahara, K., Kume, S., Koya, D., Yasuda-Yamahara, M., Takeda, N., et al. (2018). Role of dietary amino acid balance in diet restriction-mediated lifespan extension, renoprotection, and muscle weakness in aged mice. Aging Cell 17, e12796. doi:10.1111/acel.12796
Yue, S., Wang, L., DeMartino, G. N., Zhao, F., Liu, Y., and Sieber, M. H. (2022). Highly conserved shifts in ubiquitin-proteasome system (UPS) activity drive mitochondrial remodeling during quiescence. Nat. Commun. 13, 4462. doi:10.1038/s41467-022-32206-2
Zhang, J., Pavlova, N. N., and Thompson, C. B. (2017). Cancer cell metabolism: The essential role of the nonessential amino acid, glutamine. Embo J. 36, 1302–1315. doi:10.15252/embj.201696151
Keywords: amino acid metabolism, mitochondrial homeostasis, TCA cycle, respiratory chain, proteasome, amino acid recycling, lifespan
Citation: Li Q and Hoppe T (2023) Role of amino acid metabolism in mitochondrial homeostasis. Front. Cell Dev. Biol. 11:1127618. doi: 10.3389/fcell.2023.1127618
Received: 19 December 2022; Accepted: 16 February 2023;
Published: 27 February 2023.
Edited by:
Alessandro Luciani, University of Zurich, SwitzerlandReviewed by:
Sean Froese, University Children’s Hospital Zurich, SwitzerlandDario Brunetti, University of Milan, Italy
Copyright © 2023 Li and Hoppe. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Thorsten Hoppe, thorsten.hoppe@uni-koeln.de